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Clinico Pathological Study Of Melanocytic Skin Tumors in Yemeni Patients 
 




Melanocytic nevi are important primarily because of their histogenic relation to cutaneous melanoma. Acquired 
melanocytic nevi, are believed to have been developed from epidermal melanocytes that completed their migration 
from the neural crest. This study has been conducted to provide baseline data on the character of benign and 
malignant melanocytic skin tumor in Yemeni patients. A retrospective study from records in which 40 cases were 
reviewed  out of 60 cases with pigmented skin lesions which were histologically examined to exclude malignancy 
during the period from 2006 to 2014. The results and observations were organized and interpreted in light of 
demographic, clinical and histopathology findings. A total of 40 pigmented skin lesions were histologically reported 
during the period under review. The male were 13 and 27 females patients with a male to female ratio was 1.2.08. 
Maximum of the cases were seen in the age group of 21 to 40 years, with the youngest patient being 1 year and the 
oldest being 100 years. Melanocytic nevi were the most common pigmentary lesion which accounted for 72.5 % of 
the cases among them intradermal nevus which constituted 17 (42.5 %) followed by melanoma (27.5%). The most 
common site of melanoma was the  extremities  9  (81.8%), while face 22 (75.9 %) was the commonest site for nevi. 
In this study, the benign pigmented lesion was  more common than   malignant melanoma. Further studies cover 
another   geographic areas in Yemen are needed.  
Key words: Nevi, Melanoma, Melanocytic lesion, Histopathological study.  
 
Introduction: 
Pigmented lesions refer to melanocytic 
proliferations. They are composed of one or 
more of three related cell types: melanocytes, 
nevus cells or melanoma cells, each of which 
may be located in the epidermis or the dermis 
[34] Cutaneous melanoma which is one of the 
most serious skin cancers. Their incidence varies 
throughout the world. In Western countries, 
cutaneous melanoma is a relatively common 
malignancy, especially in populations with 
lighter skin colors [20]. According to World 
Health Organization, the number of melanoma 
cases worldwide is increasing faster than any 
other cancer [27]. According to the International 
Agency for Research on Cancer, its incidence is 
the highest in Queensland, Australia but is also 
high in Auckland, New Zealand [35]. In the 
USA, melanoma is the fifth most commonly 
diagnosed cancer [33]. The incidence is low in 
Asian populations [32], but there is a definite 
upward trend in Koreans [5].  
Sun exposure plays a primary and supporting 
role in most melanoma tumors. There is an 
evidence  for the four main cutaneous types of 
melanomas, the pattern of excess sunlight 
exposure which is most damaging varies . Host 
susceptibility factors include dysplastic nevi, 
increased number of nevi, freckling, family 
history of melanoma, fair complexion, light eyes, 
and blonde or red hair [39]. Nevi and other 
benign pigmented lesions, except for their 
cosmetic significance, are important as simulants 
of melanoma and as potential precursors of 
melanoma [37]. Identifying individuals at greater 
risk of developing melanoma are important. 
Therefore, this study was conducted to clarify the 
frequency and clinical presentation of melanocytic 
skin tumors and also because no study done before  
included  all melanocytic type   .  
 
Subjects and methods:  
 This is a retrospective, descriptive study 
included a total of 40 cases with pigmented skin 
lesions (1 year to 100 years) out of 60 cases 
referred to Private Pathology Clinic in Al-
Mansoora, Aden Governorate to exclude 
malignancy during the period (2006 – 2014). The 
non- melanocytic lesions were excluded.  The 
following variables  age, sex, and residence of 
patients, localization of lesion and   the 
histological  finding were analyzed by using 
SPSS/Windows, Version 21.  
Results:   
The most affected age group was (21-40 years) 
old (37.5%) with   mean age of 41.06 years, and 
SD ± 24.8.72.  Thirteen (32.5 %) of them were 
males and 27 (67.5%) were females. The male to 
female ratio was 1.2.08 (Table 1). Out of a total 
40 cases, melanocytic nevi were the most 
common pigmentary lesion which accounted for 
72.5% of the cases among them intradermal 
nevus which constituted 17 (42.5%) followed by 
compound nevi 4 cases (10%), junctional 3 cases 
(7.5%), Spitz nevi were 3 cases (7.5%), blue 
navus and spindle cell nevi both constituted 
(0.5%). The  Majority of the benign melanocytic 
lesions 22 cases (75.9%) were located on the 
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face and scalp (Table 2). Melanoma were 11 
cases (27.5%). It was observed in 5 males (45.5 
%) and 6 females (54.5%). Melanoma was found 
more commonly on lower extremity 9 cases 
(81.8 %) (Table 3), only one case (9.1%) had 
metastases to inguinal lymph node. 
 
Table 1: Demographic Characteristics of Melanocytic Skin Tumors (n=40) 
 
Character No % 
Sex   
 Male  13 32.5 
 Female 27 77.5 
M:F  1 : 2.08 
Age (n=33)   
 1-20 6 18.2 
 21-40 15 45.5 
 41-60 4 12.1 
  >60 8 24.2 
Mean ± SD =41.06 years ± 24 .87    
Residency   
IBB                 17 42.5 
Aden                                    11 27.5 
Lahaj        5 12.5 
Abyian    4 10 
Shabowi    1 2.5 
Hadramooth            1 2.5 
Almahra   1 2.5 
Un-specified age were 7 cases one of them melanoma. 
 
Table 2: Clinical and Pathological Characteristics of Patients with Nevi (n =29) 
 

























 Histological subtypes  
Intradermal nevi    
Compound nevi   
Junction nevi   
Spitz nevi   
Spindle nevi   
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Table 3: Clinical and Pathological Characteristics of Patients with Cutaneous  Melanoma 
 


























Histological subtypes  
  Acral lentiginous melanoma  
  Nodular melanoma  
 Superficial Spreading melanoma 
   
Metastasis: 
  Yes 






































































This retrospective study, addressed the 
melanocytic skin lesions. The melanocytic group 
comprised of benign melanocytic nevi, and 
malignant melanoma. 
In India, in a study of clinical records, Sri 
Gayathri et al. [36], reported that benign nevus 
were the commonest one (74%), and malignant 
melanoma  constituted (2.2 %). A similar finding 
from India in a study for 44 cases with 
pigmented skin lesions, also has been reported by 
Suvernakar et al. [37],  in that benign 
melanocytic lesions was the most prevalent but 
with a lower frequency rate ( 27.27 %) and  
malignant melanoma which constituted (11.36 
%) and the commonest histologic types of nevi 
lesions were intradermal nevi (58.3%), followed 
by compound nevi (33.3%).  This finding nearly 
similar to our finding in which benign lesions  
constituted the commonest melanocytic (72.5%) 
lesions. Intradermal nevi (42.5%) was the 
commonest, followed by compound nevi (10 %). 
Melanoma represented (27.5%).  
Laishram et al. [21], in Imphal, also in a 
retrospective analysis of 183  cases with  
pigmented skin lesions reported  higher rate 
(74.3%) of melanocytic nevi than  melanoma 
which constituted (9.8%).  
The frequency of cutaneous melanoma varies 
throughout the world. The highest rates of 
cutaneous malignant melanoma (CMM) belongs 
to Scandinavia (especially Sweden) with 15 
cases per 100,000 inhabitants, and the lowest 
rates are from the Mediterranean countries (about 
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5 – 7 cases per 100,000 inhabitants per year [15]. 
Lower incidence rates by  Alwunais and Ahmed 
(3.7%); Al-Maghrabi et al., (4.1%);  and 
Alzolibani et al., (11.7%) have been reported  
from Dammam, Al-Baha, and  Al-Qassim 
Region, and Saudi Arabia respectively [2,1,3]. 
In the current study, the majority were in the age 
group of 21-40 years (37.5 %), followed by (20 
%) in the age group of > 6o years. The male to 
female ratio was 1:2.08. In contrast, Youl et al. 
[41], reported (52.41%) of the total cases in >50 
years age group and M:F ratio of 1.4:1. 
Suvernakar. et al. [37], reported (47.73%) who 
were in the age group of 61-80 years, followed 
by (22.73%) in the age group of 21-40 years and 
M:F ratio of 1:1.1. This difference may be due to 
that they included in their study both 
melanocytic and non - melanocytic skin lesions 
and lack of data of age recording regarding some 
of cases in this study. 
Incidence rates of melanoma differ between 
genders, ages, ethnic groups, and regions. Forsea 
et al. [14], reported that in Europe, there is a 
discrepancy concerning sex predominance. The 
majority of Western and Northern European 
countries report higher incidence rates in females 
vs. males, whereas in most Central, Eastern and 
Southern European countries melanoma 
predominates in men [14]. Balaban et al., in a 
retrospective study among 172 patients with 
primary melanoma from Bosnia and 
Herzegovina reported also that melanoma was 
equally common in women and men [4]. In 
Brazil, also in an epidemiological study by 
Ferrari et al.; Paek et al. ; and Tamir et al. 
[13,30,38],  the authors reported that CMM 
affected men and women equally. Nasser in his 
study for individuals from Blumenau in south 
Brazil showed a predominance among females 
than males [28]. Countries with a high CMM 
incidence, such as Australia, tend to have a slight 
predominance of females over males or a balance 
between genders [8] whereas Marks, and 
Marrett et al.,[25,26] found that  there was a 
higher rate of CMM in men.  This is similar to a 
study carried by Brady et al., whom reported that 
men are more likely than women to develop 
melanoma [7]. Also, in a study conducted in 
Yazd, a central region of Iran, the authors 
showed that   males were 1.5-times more likely 
to have melanoma than females [29]. 
In this study, the most affected age groups with 
cutaneous melanoma was over 60 years old 7 
cases. This is similar to the data published in 
many literature [1,17,22,28].   
When comes to anatomical localization. In our 
study, the majority of melanoma cases (9 cases, 
81.8%) occurred in the extremities. This is in 
agreement with a study carried in India by Sri 
Gayathri et al. [36], in which the authors 
confirmed that the lower limbs were the most 
common anatomic sites and also  study carried 
by  Erdei and Torres  [11]. Higher incidence rate 
(62%) was reported by Hussein et al., in Egypt 
[17], Balaban et al.[2],  reported back and the 
limbs were the most common sites. In contrast, 
to a study carried in south of Brazil, the authors 
reported that trunk (30.19%), was the most 
commonly affected site followed by the upper 
limbs (19.34%) Lima et al.[23],. on the other 
hand, in a study for 20 years duration from 
cancer registry center in Yazd (Iran) the authors 
[29] mentioned that the face is the most common 
area (38%) of involvement. In this study, the 
gender difference was speculated to be due to 
clothing and body covering customs, as well as 
lower levels of employment outside the home for 
women. Bulliard et al. [9], in his study between 
two phenotypically comparable populations, 
New Zealand and Canada population, showed 
that the site affection differs among the two 
populations, in New Zealand patients, lower 
limbs were the most common site, while among 
Canadian patients, the trunk was the commonest 
site. In the current study, ALM was the most 
common histological subtype representing 
(72.7%) of melanoma cases. This result was 
similar to other studies carried out  such as a 
study among 177 Korean patients  and in 
Singapore in a retrospective study for 48 patients 
with histological confirmation of melanoma in 
which the authors reported acral as the most 
common type but with higher incidence rates 
85.9% and 50%, respectively [19,22]. This is in 
contrast with western populations studies where 
ALM represents 2%  to 3% of all   melanoma 
[6]. 
Whiteman and others [40,10], have hypothesized 
that the anatomic site at which a melanoma 
develops is reflective of the susceptibility of host 
melanocytes to proliferate in response to 
sunlight. 
Gender differences in body site distribution of 
melanoma lesions have been thought to be a 
result of inherent differences between men and 
women. Differences in clothing, hair style, 
occupation, sun-seeking behavior, preventive 
measures, and seeking medical care have all been 
considered as potential reasons for the higher 
incidence of lesions on the lower extremities in 
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women and lesions of the head, neck, and trunk 
areas of the body in men Bulliard et al. [9],. 
However, the reasons for the observed gender 
differences may go beyond societal differences 
among males and females, and depend on the 
relationship between steroid hormones [31] . 
In the international literature a higher rate for 
CMM has been observed among women, 
predominantly in geographic regions with low 
sunlight indices. These findings suggest the 
existence of a gender difference with changes in 
latitude. In this study, higher rate of CMM has 
been detected among individuals from low 
sunlight indices as in literature. 
Conclusion: Nevi are vastly more common than 
melanomas the extremities which were the most 
common site for melanoma and slight 
predominance among females. 
Limitation: Only melanocytic pigmented lesions 
were included in the study. No data available 
concern this topic from other clinics during data 
collection with explanation of some of our 
colleagues pathologist that data in their clinic 
was lost because of war. 
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نها منحدرة من الخال ا الم الن ة لل شرة أتكمن أهم ة الشامات الم الن ة أساسًا لعالقتها النسیج ة  م النوما الجلد. والشامه الم تس ة  عتقد 
ورام الجلد ة الم الن ة ألاتوفیر الب انات األساس ة عن إلى هده الدراسة الوصف ة االسترجاع ة : تهدف . التي هاجرت من عصب في الدماغ
 انت  من الذینحالة  60ورام الجلد الم الن ة من أصل ألحالة  40شملت هده  الدراسة االسترجاع ة   .الخبیثة والحمیدة في مرضى  منیین
 . كلین   ًا ونسیج اً أو م. وتم ترتیب وتدو ن الب انات د موغراف ًا 2014م إلى 2006ئة عام، خالل الفترة من تتراوح أعمارهم من سنة إلى ما
 ور إلى اإلناث ذالحالة، و لغت نس ة  27حالة وعدد اإلناث   13ور  ان ذالن عدد أتبین من خالل هده الدراسة  عد المراجعة والتحلیل 
سنة، و ان أقل عمرًا سنة وأكبر عمرًا مائة سنة. و انت الشامة  40 - 21من  ةالعمر ظمى هم من الفئة ، وأن الغالب ة الع1:2.08
حالة)،  17% (لعدد 42.5فات الم الن ة  ما فیها الوحمات األدم ة التي ش لت نس ة آلا% من 72.5الم الن ة هي األكثر شیوعًا، بنس ة 
لت نس ة حاالت التي ش  9ماكن تواجد للم النوما حیث بلغ عدد الحاالت أسفلى هي أكثر %، و انت األطراف ال27.5والم النوما نس ة 
ن اآلفات أ% ).  وخلصنا إلى 75.9حالة ( 22 أكثر شیوعًا للشامات الحمیدة، حیث بلغ عدد الحاالت ه%)، بینما ش ل الوج81.8(
  .خر  من ال منأراسات أخر  تغطي مساحات جغراف ة نوصي  ق ام د. الم الن ة الحمیدة هي األكثر إنتشارًا من الم النوما الخبیثة
  .فات الم الن ة ، دراسة نسیج ة  اثولوج ةآل: الشامات ، الم النوما ، االكلمات المفتاح ة
  
  
  
 
 
 
 
 
